MARKET

DGX

DGX

Quest Diagnostics Inc
NYSE
230.97
+0.16
+0.07%
After Hours: 230.97 0 0.00% 16:20 10/09 EDT
OPEN
227.86
PREV CLOSE
230.81
HIGH
232.18
LOW
227.86
VOLUME
775.43K
TURNOVER
--
52 WEEK HIGH
247.92
52 WEEK LOW
168.34
MARKET CAP
25.49B
P/E (TTM)
24.55
1D
5D
1M
3M
1Y
5Y
1D
Illumina Inc. Stock Rallies 5.1%, Outperforms Peers
Dow Jones · 1h ago
Illumina Inc. stock outperforms competitors on strong trading day
MarketWatch · 1h ago
These healthcare stocks have the highest EPS revision grade ahead of Q3 results
Seeking Alpha · 9h ago
Is Quest Diagnostics (DGX) Undervalued Following New Haystack MRD Study Results?
Simply Wall St · 14h ago
Natera: Priced To Perfection Amidst Rising Competitive Threats
Seeking Alpha · 2d ago
Quest Diagnostics Is Maintained at Overweight by Barclays
Dow Jones · 2d ago
Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $260
Benzinga · 2d ago
Quest Diagnostics price target raised to $260 from $250 at Barclays
TipRanks · 2d ago
More
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. It provides diagnostic insights from the results of its laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and its connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. Its other customers include health plans, employers, emerging retail healthcare providers, government agencies, and others. Its services are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

Webull offers Quest Diagnostics Inc stock information, including NYSE: DGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DGX stock methods without spending real money on the virtual paper trading platform.